The document is a regulatory intimation regarding the availability of the recording for an Investors/Analyst Earnings Conference Call that was previously held.
The conference call discussed the Unaudited Financial Results of the Company for the first quarter ended June 30, 2026 (Q1 FY27).
The audio recording of the call has been uploaded to the Company's website and is accessible at the provided link: https://www.aartipharmalabs.com/q1-fy-27.
This intimation is made in continuation of a previous communication dated August 03, 2026, and is submitted under the compliance requirements of Regulation 30 of the SEBI (LODR) Regulations, 2015.
The document does not specify the exact date and time of the original call, management participants, or whether any unpublished price sensitive information (UPSI) was shared.
Additional Notes Section
The document is a formal compliance letter addressed to the listing departments of both BSE Ltd. and the National Stock Exchange of India Limited.
No financial highlights, guidance references, or presentation summaries are included in this specific announcement; it solely concerns the availability of the call recording.
The letter is digitally signed by Jeevan Bhargav Mondkar, who is identified as the Company Secretary and Legal Head (ICSI Membership No. A22565).
